Link to publication Citation for published version (APA): Gelderman, K., Hultqvist, M., Holmberg, J., . T cell surface redox levels determine T cell reactivity and arthritis susceptibility. Proceedings of the National Academy of Sciences, 103(34), 12831-12836. DOI: 10.1073/pnas.0604571103 General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
Introduction
Reactive oxygen species (ROS) are generally thought to be harmful and to play a disease enhancing role in autoimmune diseases like arthritis (1, 2) . However, we have found that a decreased capacity to produce ROS due to polymorphisms in Ncf1, increases susceptibility for autoimmunity and arthritis (3, 4) . Ncf1 encodes the neutrophil cytosolic factor 1 (Ncf1, alias p47phox), the activating protein in the NADPH oxidase complex that produces ROS upon activation. In the rat, a single nucleotide polymorphism (SNP) in the Ncf1 gene was identified by positional cloning to be one of the strongest genes in regulating both oxidative burst and arthritis (3) . In the mouse a spontaneous mutation was identified that affects splicing and results in expression of truncated, less functional Ncf1 protein (5) , which also resulted in increased arthritis and autoimmunity (4) . Hence, it was clear that the Ncf1 gene that controls oxidative burst also controlled the autoimmune response and severity of arthritis in both rats and mice.
It has been shown that arthritis as induced by immunization with pristane in rats (PIA) and collagen in mice (CIA) expressing polymorphic Ncf1, is T cell dependent. In the rat model, only T cells from DA.Ncf1
DA rats (DA rats with the mutated Ncf1 DA allele from the DA rat) can transfer disease to naïve DA.Ncf1 DA recipients, whereas T cells from the congenic DA.Ncf1 E3 (DA rats with the wildtype Ncf1 E3 allele from the E3 rat)
cannot (3, 6) . In the mouse model, a mutation in Ncf1 results in an increased DTH response and serum levels of anti-collagen type II IgG antibodies (4), indicating enhanced activation of autoreactive T cells. Thus, Ncf1 somehow influences autoreactive 4 T cells during immune priming to become arthritogenic, either via cell-cell contact or via the cellular milieu.
To function properly, cells need to maintain an adequate redox balance (7) .
Recent work indicates a role for reduced cell surface thiols (-SH) as targets of redox regulation in the immune system (8) . Such redox sensitive moieties at the cell surface mostly are in an oxidized state, probably because they are exposed to the oxidizing extracellular environment (9) . Changes in redox balance of extracellular proteins can result in modified receptor activation or in modification of proteins that act as redox sensors (10, 11) . A decrease in NADPH oxidase function, resulting in decreased ROS production, might interfere with cell surface redox levels of immune cells (12) , resulting in defective immune regulation at a certain time-point during the immune response.
T cell function is markedly influenced by alterations in the redox balance. It is known that lymphocytes require a reducing milieu for optimal proliferation and activation (13, 14) . Exposure to ROS has been demonstrated to down-regulate T cell activity (14, 15) and a decrease in intracellular redox levels impairs T cell function (16) .
Hence, our aim was to determine whether a decreased capacity to produce ROS affects the redox balance of T cells and thereby affects the downstream effector mechanisms associated with the identified Ncf1 polymorphism controlling arthritis severity.
Results

T cells from Ncf1 mutated rats have higher levels of reduced cell surface thiols
To explain how oxidative burst influences T cell activation we investigated if the redox balance in T cells is disturbed in animals with a decreased NADPH oxidase function. It has been described that ROS production by the NADPH oxidase complex and the redox balance are linked (12 (Fig 1a) . When staining for Ncf1 expression, a clear difference was observed between the strains when looking at neutrophils, in contrast to T cells where no Ncf1 staining was detected as compared to the control, where an irrelevant first antibody was used (Fig 1b) .
Next, we investigated the cell surface and intracellular redox levels of T-cells in the different strains. Cell surface redox levels were determined by flowcytometry after staining the cells for reduced thiol (-SH) groups and cell-specific markers (16) . T cells in blood from Ncf1 mutated DA.Ncf1 DA rats were shown to have a higher number of cell surface thiols as compared to those from Ncf1 wildtype DA.Ncf1 E3 rats (Fig 1c) . Higher levels of T cell surface thiols in DA.Ncf1 DA rats were also observed in spleen and inguinal lymph (LN) node T cells (not shown). Other cell types showed tendencies to have increased amounts of cell surface thiols in Ncf1 mutated animals (macrophages, neutrophils, B-cells), although these were not significantly different. Intracellular thiol 6 levels of T cells were determined by flowcytometry with monochlorobimane (MCB), reacting with intracellular GSH (17) . No difference in intracellular thiol levels between the strains was detected in T cells (Fig 1d) . In contrast, the extracellular milieu was shown to be genetically controlled. Plasma of DA.Ncf1 DA rats was shown to contain more reduced thiol groups on plasma proteins as compared to DA.Ncf1 E3 rats (Fig 1e) as determined with an assay utilizing 5,5'-dithiobis(2-nitrobenzoic acid) (DTNB) (9, 13).
Similar data were obtained for the Ncf1 mutated mice (see supplementary Fig 1a-e) .
The number of cell surface thiols can be artificially increased
To study the effect of higher numbers of cell surface thiols on T cell function, we wanted to change this number artificially. Both reduced glutathione (GSH) and N-acetyl-cysteine (NAC) are described to increase the amount of cell surface -SH groups on human cells (9) . Heparinized rat blood was treated with 4 mM of GSH or 4 mM of NAC (16) and stained for cell specific markers and reduced surface thiols (-SH). No hemolysis was performed, since that influenced the staining of surface -SH. Both GSH and NAC increased the number of T cell surface thiols (Fig 2a, b) . GSH, however, did not influence intracellular redox levels whereas NAC increased the number of intracellular thiols (Fig   2c) APC's were either treated with PBS or with 4 mM GSH to increase the amount of cell surface -SH groups. Higher numbers of cell surface thiols on T cells were shown to increase IL-2 production, whereas a higher number of thiol groups on APC's did not (Fig   3a) . In absence of CII, no differences in IL-2 production were observed between GSH and PBS treated conditions. These data indicate that the number of cell surface thiols on T cells determines their proliferative response in vitro.
To investigate the role of T cell surface thiols in vivo we used the rat model, since it was shown before that T cells from DA rats could transfer pristane induced arthritis 
Increasing the number of cell surface thiol groups on T cells increases arthritogenicity
The (Fig 4b) .
After transfer, the number of cell surface thiols in blood was followed in time.
However, no significant increase in numbers of cell surface thiol levels of T cells or any other cell type was observed (Fig. 4c) . Apparently the number of transferred T cells was too low to change the number of -SH on all T cells. In plasma no differences in -SH group numbers were observed either (not shown).
GSH treated T cells become effector cells
Next, we wanted to study the survival and functional state of the injected GSH treated donor cells. Since CFSE staining diluted out to background levels within two days, an allelic marker was used to follow the transferred cells for a longer time. A similar transfer protocol was used as described for the CFSE transfer but the cells were now injected in irradiated congenic DA.1I rats, which do not express the MHC Class I molecule RT1A a (19) . Rats were sacrificed at day 7 after transfer, at disease onset or at Indeed this experiment confirmed and extended the short term CFSE experiment; 7 days after transfer, GSH treated T cells had expanded significantly more in inguinal and draining LN, and in inguinal LN also at day 12. The GSH treated T cells also reached the joints in higher numbers than PBS treated cells (Table 2) . Gating on all donor (RT1A a+ ) cells (gate M1) it was shown that these were mainly CD4 + T cells, confirming that CD4 + T cells are indeed the cells that proliferate upon transfer (Fig 4d) . Hence, the GSH treated cells survive equally well, are still present in higher number compared to PBS treated cells during disease, are relatively expanded in the joint draining lymph nodes and reach the synovia.
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The next issue to clarify was whether the CD4 + RT1A a+ double-positive donor T cells maintained their increased levels of cell surface -SH in vivo. The cells were isolated from various tissues 12 days after injection and surprisingly, a maintained higher level of -SH groups was observed on donor T cells isolated from blood and inguinal LN, compared to host T cells. However, in cells from spleen, thymus, draining lymph nodes or affected joints these levels had reverted to normal at this time point (Fig 5a) . To investigate the longevity of GSH treatment in an in vitro system, we treated the HCQ10 hybridoma T cells with GSH or PBS and then labeled them with CFSE. The increased level of cell surface -SH staining on the GSH treated cells was maintained until the third division when it started to decrease, reaching similar levels as in the PBS treated group after 6 divisions (Fig 5b, c) . These data shows that the reduced T cell membrane status could be maintained through several rounds of cell division and also in vivo in the blood and lymph nodes, but not when they finally arrive in the joints.
Decreasing the number of cell surface thiol groups on T cells decreases arthritogenicity
To confirm that the observed effects of GSH treatment were indeed mediated via increasing cell surface -SH groups and not by a side effect of GSH we performed the reverse experiment. First it was investigated if treatment with oxidized glutathione (GSSG) resulted in a decrease in T cell surface -SH groups. This was shown to be the case (Fig 6a) . To investigate if this decrease in cell surface -SH resulted in decreased T cell activation in the mouse system, we compared IL-2 production by HCQ10 T hybridoma cells after GSSG or PBS treatment. It was shown that less IL-2 was produced when T cells were treated with GSSG, indicating that decreasing cell surface -SH suppresses T cell activation (Fig 6b) . In line with this, we observed in vivo that in rats a decrease in T cell surface -SH due to GSSG treatment led to significantly less severe arthritis in a spleen cell transfer from immunized DA.Ncf1 DA rats to DA.Ncf1 DA rats (Fig   6c) .
Discussion
We here provide evidence for a new mechanism whereby ROS produced by the NADPH oxidase complex determine the T cell surface redox level, thereby controlling T cell reactivity and the development of arthritis. Although our findings are opposite to the current dogma that ROS are attenuating an immune response, we earlier provided genetic evidence that a decrease in ROS production by the NADPH oxidase complex increases arthritis severity in both rats and mice. In search for a mechanism how a decrease in ROS could operate in regulating the immune response we studied T cell activation by the redox balance in our animal models.
It has previously been shown that T cell maturation and proliferation are influenced by ROS (20) . Although most previous reports focused on the intracellular redox balance, some of them showed that a reducing extracellular environment increases T cell responsiveness in vitro and in situ (8, 9, 16, 21) . We now show that an increase in The second possibility is that T cells obtain increased cell surface thiol numbers in the periphery, for example during trafficking in the blood. We show that plasma of animals with polymorphic Ncf1 contained higher levels of -SH groups than that of wildtype animals. This might be due to a decreased level of systemic ROS released during e.g. phagocytosis, thymic selection or antigen presentation. However, the observation that T cells do not proliferate better when they are in close contact with APC's in absence of peptide, makes this possibility less likely.
As the present experiments clearly show, the redox levels of T cell surfaces could be maintained several cycles of division after transfer and also lead to enhanced T cell activation in vivo. However, arthritis developed only several days after the cell surface redox levels already decreased on the donor T cells. In addition, donor T cells that migrated to the joints as effector cells, before arthritis developed, did not maintain this 14 increased level of cell surface -SH. These findings argue for that the redox levels regulate immune activation rather than direct effector functions in the joints. This might be underscored by the previous finding that plasma of RA patients contains significantly higher levels of ROS as compared to matched controls (30, 31) ). Also in arthritic rats the level of ROS in spleen, thymus and lymphocytes was increased (31, 32) . These findings seem opposite to our results, but probably just reflect the fact that Ncf1 function is also enhanced as a result of the inflammatory process. In the effector phase of disease, where joints are destroyed and accumulation of ROS producing cells in the joint has taken place, the physiological buffering capacity is exceeded and the result is local and systemic oxidative stress, when ROS possibly could be harmful rather than beneficial.
Cell surface -SH groups might therefore rather be used as an arthritis predicting parameter than as a diagnostic tool.
In conclusion, we here show that the number of thiol groups on the cell surface of T cells is regulated via ROS, produced by the NADPH oxidase complex and that the level of T cell surface -SH groups influences activation, proliferation and arthritis development. 
Methods
Arthritis induction and evaluation
Arthritis was induced in 8-14 week old rats by injecting 200 μl (disease) or 500 μl (T cell transfer) of pristane (2,6,10,14,-tetramethylpentadecane; Sigma Aldrich Inc., Milwaukee, WI) s.c. at the base of the tail. Arthritis development was monitored using a macroscopic scoring system: each swollen or red toe, midfoot digit or knuckle received one point and each swollen ankle 5 points, resulting in a maximal score of 60 per rat.
Antibodies
Anti-rat T cell receptor (R73), anti-rat Gr1 (HIS48), anti-rat CD4 (OX-35) anti-rat CD8 
Flowcytometry
The relative number of cell surface thiol groups on different cell types was determined 
Measurement of plasma -SH groups
Plasma was diluted 1/2 in PBS and equal amount of 400 μM DTNB was added. OD450
was measured and the relative number of plasma thiols was calculated according to a GSH standard.
GSH and NAC treatment
To increase the number of cell surface thiol groups, cells were treated with 4 mM reduced glutathione (GSH; Sigma) or 4 mM N-acetylcysteine (NAC; Sigma) in PBS. To decrease cell surface thiol groups 2 mM of oxidized glutathione (GSSG; Sigma) diluted in PBS was used. All treatments were done for 15' on ice.
T cell activation assays
APC's were isolated from naïve mouse spleen suspensions as follows: cells were taken 
T cell transfer
Rats were immunized with 500 μl pristane. At day 14, spleen cells and inguinal LN CD4 + T cells (purified by panning; >94% CD4 + T cells) were cultured for 48 hrs in DMEM+++ with 3μg/ml Concanavaline A (ConA; Sigma) at 37°C (6) . Then cells were treated with 4 mM GSH in PBS or PBS as a control, in 5 ml for 175x10 6 
